|
End-of-day quote
Amman S.E.
2026-09-14
|
5-day change | 1st Jan Change | ||
| 2.000 JOD | +6.95% |
|
+5.26% | +25.00% |
| 07-21 | Philadelphia Pharmaceuticals Company Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 04-27 | Philadelphia Pharmaceuticals Q1 profit 255,632 dinars | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +6.95% | +5.26% | +1.01% | +19.05% | +25.00% | +30.72% | +39.86% | +44.93% | -30.07% | 21.16M | |
| 0.00% | -0.42% | -1.53% | +1.80% | +7.76% | +14.38% | +61.48% | +140.71% | +136.83% | 45.9B | |
| +3.39% | -1.66% | -6.16% | +6.67% | +27.07% | +38.56% | +102.42% | +130.53% | +149.12% | 38.7B | |
| -0.20% | -1.24% | -2.44% | +4.00% | +20.73% | +6.78% | +71.57% | +98.12% | +184.69% | 11.43B | |
| +0.11% | -1.03% | -5.06% | +0.61% | -10.07% | -12.86% | +9.56% | +42.46% | +127.35% | 11.38B | |
| +0.96% | +0.57% | +1.55% | -0.57% | +29.31% | +19.32% | +148.82% | +136.49% | +337.50% | 9.09B | |
| -0.47% | +0.16% | -3.08% | +5.79% | +27.72% | +27.34% | +36.96% | +48.24% | +117.24% | 7.3B | |
| +2.32% | +1.75% | -1.00% | +6.00% | +9.76% | +39.44% | -18.52% | -11.80% | -8.18% | 7.13B | |
| -0.51% | -0.78% | +2.88% | +12.15% | +17.73% | +17.32% | +181.38% | +361.81% | +160.29% | 6.98B | |
| +0.61% | -5.43% | -14.67% | -1.88% | -39.90% | -43.52% | +5.23% | +11.24% | +6.93% | 4.89B | |
| -0.46% | -0.78% | -6.06% | +13.42% | +26.14% | +36.39% | +109.51% | +139.76% | +164.99% | 4.57B | |
| -0.57% | -1.02% | +8.83% | +7.83% | +33.88% | +55.10% | -8.02% | -32.09% | -51.50% | 4.3B | |
| +1.16% | +0.71% | -8.65% | +19.70% | -5.60% | -13.61% | +71.21% | +52.29% | - | 3.68B | |
| +0.36% | -8.54% | +6.96% | +0.40% | +40.43% | +31.18% | +738.70% | +361.36% | +128.02% | 3.5B | |
| -1.36% | -2.84% | -6.33% | -5.31% | -8.12% | -2.11% | +42.45% | +197.60% | +713.75% | 2.81B | |
| -0.89% | -5.45% | -17.41% | -41.09% | -32.86% | -28.23% | +75.20% | +206.68% | +1,663.84% | 2.71B | |
| -0.11% | +0.87% | +0.38% | +6.96% | -19.08% | -26.42% | +38.76% | +111.01% | +11.81% | 2.68B | |
| -1.29% | -5.11% | -8.13% | -18.95% | -8.64% | -11.38% | +14.04% | - | - | 2.45B | |
| -0.15% | -1.77% | -12.36% | -17.56% | -14.99% | -7.69% | +34.51% | +12.97% | +47.78% | 2.32B | |
| +0.69% | -3.98% | -13.33% | +1.08% | +0.03% | -44.39% | +63.95% | +62.13% | - | 2.23B | |
| Average | +0.52% | -0.95% | -4.23% | +1.01% | +6.32% | +6.32% | +90.95% | +111.28% | +227.08% | 8.7B | |
| Weighted average by Cap. | +0.81% | -2.21% | -3.45% | +3.02% | +12.42% | +16.16% | +83.25% | +120.86% | +170.55% |
- Stock Market
- Stocks
- PHIL Stock
- Sector Philadelphia Pharmaceuticals Company
Select your edition
All financial news and data tailored to specific country editions
